IP Library › Granted Patent US 10,611,795
Granted Patent B2
US 10,611,795 · App. 15/154,235 · Granted Apr 7, 2020

Methods for viral inactivation using eco-friendly detergents

Inventors: Susan Fisher (San Carlos, CA); Qi Chen (Hillsborough, CA); Lenore Norling (Pleasanton, CA)
Assignee: Genentech, Inc.
C07K1/36C07K1/14C07K1/18C07K1/22A61K38/00A61L2/0088A61L2202/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,611,795
App. No.
15/154,235
Granted
Apr 7, 2020
Kind
B2
Abstract

The invention provides for methods of inactivating virus in product feedstream in a manufacturing process of a therapeutic polypeptide using an environmentally compatible detergent. The environmentally compatible detergent does not adversely affect product quality while effectively inactivating virus in the feedstream.

Claims (55)

1. A method of inactivating virus in a product feedstream in a manufacturing process of a therapeutic polypeptide, the method comprising the step of subjecting the feedstream to a detergent, wherein the detergent is environmentally compatible, wherein the environmentally compatible detergent has a CAS registry number of CAS 68515-73-1, CAS 58846-77-8, CAS 59122-55-3, CAS 110615-47-9, CAS 64366-70-7, CAS 68937-66-6, CAS 69227-22-1, CAS 27252-75-1, or CAS 132778-08 6.

2. The method of claim 1 , wherein the method maintains product quality of the therapeutic polypeptide compared to a method using Triton X-100 or a method without detergent.

3. The method of claim 2 , wherein the therapeutic polypeptide's product quality results in no more than a 5% change in product variants out of the total polypeptide in the product feedstream.

4. The method of claim 3 , wherein the product variants do not increase by more than 5% out of the total polypeptide in the product feedstream.

5. The method of claim 3 , wherein the product variants are size variants, charge variants, oxidation variants, deamidation variants, glycation variants or variants with altered glycan profiles.

6. The method of claim 3 , wherein the product variants are acidic and/or basic product variants.

7. The method of claim 1 , wherein subjecting the feedstream to detergent does not increase fragmentation of the polypeptide by more than about 5%.

8. The method of claim 1 , wherein subjecting the feedstream to detergent does not increase aggregation in the feedstream by more than about 5%.

9. The method of claim 1 , wherein subjecting the feedstream to detergent does not reduce the yield of the polypeptide in the manufacturing process by more than about 5%.

10. The method of claim 1 , wherein the detergent is added to the feedstream to a final concentration of about 0.01% to about 10%.

11. The method of claim 1 , wherein the detergent is added to the feedstream to a final concentration of about 0.3% to about 1%.

12. The method of claim 1 , wherein the feedstream is subjected to the detergent for at least about 1 minute to at least about 48 hours.

13. The method of claim 1 , wherein the feedstream is subjected to the detergent for at least about 15 minutes to at least about 3 hours.

14. The method of claim 1 , wherein the feedstream is subjected to the detergent for at least about 1 hour.

15. The method of claim 1 , wherein the feedstream is subjected to the detergent at about 4° C. to about 30° C.

16. The method of claim 1 , wherein the feedstream is subjected to the detergent at about 15° C. to about 20° C.

17. The method of claim 1 , wherein the detergent is a non-ionic detergent or zwitterionic detergent.

18. The method of claim 1 , wherein the detergent has a hydrophile lipophile balance (HLB) from about 12 to about 15.

19. The method of claim 1 , wherein the detergent does not comprise or form octylphenol.

20. The method of claim 1 , wherein the detergent does not comprise or form peroxide.

21. The method of claim 1 , wherein the feedstream comprising the detergent is of low turbidity.

22. The method of claim 1 , wherein addition of the detergent to the feedstream does not increase the turbidity of the feedstream.

23. The method of claim 1 , wherein upon disposal the detergent's Predicted Environmental Concentration (PEC) in the receiving water body resulting from use of the detergent is below the Predicted No-Effect Concentration (PNEC) of the detergent.

24. The method of claim 23 , wherein the PEC is lower than the PNEC.

25. The method of claim 1 , wherein the detergent comprises one or more surfactants.

26. The method of claim 1 , wherein the detergent comprises one or more surfactants, preservatives, and chelating agents.

27. The method of claim 1 , wherein the feedstream comprises a harvested cell culture fluid.

28. The method of claim 27 , wherein the detergent is added to the harvested cell culture fluid.

29. The method of claim 1 , wherein the feedstream comprises a capture pool or a recovered product pool.

30. The method of claim 29 , wherein the capture pool or recovered product pool is an affinity chromatography pool.

31. The method of claim 29 , wherein the capture pool or recovered product pool is a protein A pool, a protein G pool or a protein L pool.

32. The method of claim 29 , wherein the capture pool or recovered product pool is a mixed mode chromatography pool.

33. The method of claim 1 , wherein the detergent is used in combination with an anti-foaming agent.

34. The method of claim 33 , wherein the antifoaming agent is simethicone.

35. The method of claim 1 , wherein the virus is an enveloped virus.

36. The method of claim 1 , wherein the virus is a retrovirus, a herpesvirus, a flavivirus, a poxvirus, a hepadnavirus, a hepatitis virus, an orthomyxovirus, a paramyxovirus, a rhabdovirus, or a togavirus.

37. The method of claim 1 , where in the viral log reduction value (LRV) of the detergent in the feedstream is greater than about one.

38. The method of claim 1 , wherein the viral LRV is greater than about four.

39. The method of claim 37 , wherein the LRV is calculated based on infectivity assay.

40. The method of claim 39 , wherein the infectivity assay is a plaque assay or a TCID 50 assay.

41. The method of claim 1 , wherein the method further comprises a step of filtering the feedstream after adding the detergent.

42. The method of claim 41 , wherein the feedstream is filtered at least about 15 minutes to at least about 48 hours after addition of the detergent.

43. The method of claim 41 , wherein the feedstream is filtered at least about 1 hour to at least about 3 hours after addition of the detergent.

44. The method of claim 41 , wherein the feedstream is filtered after about 1 hour after addition of the detergent.

45. The method of claim 41 , wherein the filter is an ultrafilter or a depth filter.

46. The method of claim 1 , wherein the feedstream is subjected to chromatography after addition of the detergent.

47. The method of claim 46 , wherein the chromatography is one or more of an affinity chromatography, an ion exchange chromatography a hydrophobic interaction chromatography, a hydroxyapatite chromatography, or a mixed mode chromatography.

48. The method of claim 47 , wherein the affinity chromatography is a protein A chromatography, a protein G chromatography or a protein L chromatography.

49. The method of claim 47 , wherein the ion exchange chromatography is an anion exchange chromatography or a cation exchange chromatography.

50. The method of claim 1 , wherein the therapeutic polypeptide is an antibody, an immunoadhesin, an enzyme, a growth factor, a receptor, hormone, a regulatory factor, a cytokine, an Fc fusion polypeptide, an antigen, or a binding agent.

51. The method of claim 50 , wherein the antibody is a monoclonal antibody, a chimeric antibody, a humanized antibody, a human antibody, a bispecific antibody, or an antibody fragment.

52. The method of claim 1 , wherein the therapeutic polypeptide is produced in mammalian cells.

53. The method of claim 52 , wherein the mammalian cell line is a Chinese Hamster Ovary (CHO) cells, or baby hamster kidney (BHK) cells, murine hybridoma cells, or murine myeloma cells.

54. The method of claim 1 , wherein the environmentally compatible detergent has a CAS registry number of CAS 110615-47-9.

55. The method of claim 1 , wherein the environmentally compatible detergent has a CAS registry number of CAS 68515-73-1.

Continuity (4)
Continuation PCTUS2014065391 · Nov 13, 2014
Provisional Application 61937284 · Feb 7, 2014
Provisional Application 61905075 · Nov 15, 2013
Related Publication 20160333046A1 · Nov 17, 2016
Cited By (1)
US 12,649,907